MOLECULAR BIOMARKERS AND HISTOLOGICAL PARAMETERS IMAPCT ON SURVIVAL AND RESPONSE TO FIRST- LINE SYSTEMIC THERAPY OF METASTATIC COLORECTAL CANCER PATIENTS. Radiol Oncol. 2019;53(1). Accessed September 21, 2026. https://www.radioloncol.com/index.php/ro/article/view/3168